Related Experiment Video
Updated: Jun 6, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Practical genetics for autosomal dominant polycystic kidney disease
1Divisions of Nephrology and Genomic Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada. york.pei@uhn.on.ca
Autosomal dominant polycystic kidney disease (ADPKD) diagnosis is challenging due to variable disease severity. This review covers clinical predictors, imaging, and molecular tests for ADPKD evaluation.
Area of Science:
- Nephrology
- Medical Genetics
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder, causing end-stage renal disease in ~5% of North Americans.
- Characterized by progressive renal cyst development, ADPKD is primarily caused by mutations in PKD1 or PKD2 genes.
- PKD1 mutations typically result in more severe disease than PKD2 mutations, with earlier onset of kidney failure.
Purpose of the Study:
- To review the utility and limitations of diagnostic approaches for ADPKD.
- To present an integrated strategy for evaluating individuals with suspected ADPKD.
- To address diagnostic challenges posed by genetic and environmental modifiers causing disease variability.
Main Methods:
- Review of clinical predictors for ADPKD gene types.
- Evaluation of imaging-based diagnostic tests, including ultrasonography with age-dependent criteria.
- Analysis of molecular diagnostic methods such as DNA linkage and direct gene sequencing.
Main Results:
- Standard ultrasound criteria for PKD1 may have limited utility for milder PKD2 or when gene type is unknown.
- Recently developed ultrasound criteria show high predictive value for at-risk subjects of unknown gene type.
- Molecular testing offers diagnostic capabilities for equivocal imaging, indeterminate family history, or living kidney donor evaluations.
Conclusions:
- Accurate ADPKD diagnosis requires integrating clinical, imaging, and molecular data.
- Understanding diagnostic test performance is crucial for effective genetic counseling and patient management.
- Further research into genetic and environmental modifiers may improve ADPKD prognosis and treatment.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Pedigree Analysis
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Diabetic Nephropathy